Amphiregulin antisense oligonucleotide inhibits the growth of T3M4 human pancreatic cancer cells and sensitizes the cells to EGF receptor-targeted therapy.
about
A differential requirement for the COOH-terminal region of the epidermal growth factor (EGF) receptor in amphiregulin and EGF mitogenic signalingPancreatic cancer cells require an EGF receptor-mediated autocrine pathway for proliferation in serum-free conditionsTherapeutic effect of intracolonically administered nuclear factor kappa B (p65) antisense oligonucleotide on mouse dextran sulphate sodium (DSS)-induced colitis.Targeted therapies for pancreatic cancer.Involvement of NF-κB/miR-448 regulatory feedback loop in chemotherapy-induced epithelial-mesenchymal transition of breast cancer cells.Inhibition of apoptosis by amphiregulin via an insulin-like growth factor-1 receptor-dependent pathway in non-small cell lung cancer cell lines.Tyrosine kinases in disease: overview of kinase inhibitors as therapeutic agents and current drugs in clinical trials.Expression of amphiregulin predicts poor outcome in patients with pancreatic ductal adenocarcinoma.Exocrine Gland Morphogenesis: Insights into the Role of Amphiregulin from Development to Disease.Nuclear translocation of pro-amphiregulin induces chemoresistance in gastric cancer.Autocrine and juxtacrine effects of amphiregulin on the proliferative, invasive, and migratory properties of normal and neoplastic human mammary epithelial cells.Antisense expression for amphiregulin suppresses tumorigenicity of a transformed human breast epithelial cell line.Differential Gene Expression in Ductal Carcinoma In Situ of the Breast Based on ERBB2 Status.
P2860
Q28139198-70BF2CED-D8F6-4DDE-8E88-EFDA6456A119Q28361966-D78EE7AB-300D-4CD4-855D-6D5A1621C1E0Q30856787-060B71C2-3B98-4F08-A73A-88544AC87148Q33899923-ABB4274D-9519-402F-9497-02251B68A21FQ34134513-54D84F5F-AF38-46EB-A69E-8C17644F868EQ34152476-5FA538BB-F036-4952-9FF3-CF6A07729BB0Q36181201-EAA0F546-933E-48F3-A22C-3970628BEA5FQ37080154-4E11016C-B809-4B40-8E92-A87AABA2E701Q39358786-AC01A9E7-0B42-43FF-8457-C7682C18A0C3Q39399252-5B639569-B0BE-4551-A05D-60D5058ACE9EQ40221236-29DDFCA2-2C8A-4799-A5F8-4A30A139ADAFQ40912246-81C4050D-BE37-46A7-962F-C79D2DC6C935Q51145791-C7A7717A-EBBE-47A3-BEA7-24ED1C47258C
P2860
Amphiregulin antisense oligonucleotide inhibits the growth of T3M4 human pancreatic cancer cells and sensitizes the cells to EGF receptor-targeted therapy.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh-hant
name
Amphiregulin antisense oligonu ...... EGF receptor-targeted therapy.
@en
Amphiregulin antisense oligonu ...... EGF receptor-targeted therapy.
@nl
type
label
Amphiregulin antisense oligonu ...... EGF receptor-targeted therapy.
@en
Amphiregulin antisense oligonu ...... EGF receptor-targeted therapy.
@nl
prefLabel
Amphiregulin antisense oligonu ...... EGF receptor-targeted therapy.
@en
Amphiregulin antisense oligonu ...... EGF receptor-targeted therapy.
@nl
P2093
P2860
P1476
Amphiregulin antisense oligonu ...... EGF receptor-targeted therapy.
@en
P2093
G R Johnson
H Funatomi
S A Thompson
T Ishiwata
P2860
P304
P356
10.1002/(SICI)1097-0215(19970729)72:3<512::AID-IJC21>3.0.CO;2-C
P577
1997-07-01T00:00:00Z